BIOMERICA INC. news, videos and press releases - Page 3
For more news please use our advanced search feature.
BIOMERICA INC. - More news...
BIOMERICA INC. - More news...
- Biomerica Launches New Website For Its EZ Detect™ Colorectal Disease Screening Test
- Biomerica Signs Exclusive Distribution Agreement in Canada for its New and Proprietary Helicobacter Pylori (H. pylori) Test, hp+detect™
- Biomerica Receives Notice of Allowance from Mexican Patent Office for Irritable Bowel Syndrome Food Sensitivity Testing & Treatment
- Biomerica to Participate in Upcoming Investor Conferences
- Biomerica’s Fast 15-Minute Easy to Use COVID-19 Antigen Test Now Available With Simple Nasal Swab
- Biomerica Reports 208% Increase In Q3 Fiscal 2021 Sales, Over Q3 Fiscal 2020
- Biomerica Reports Fiscal 2021 Second Quarter Financial Results and Provides Business Update
- Biomerica’s Fast 15-Minute Simple to Use Covid-19 Antigen Rapid Test Receives CE Mark
- Biomerica's InFoods® Irritable Bowel Syndrome Diagnostic-Guided Therapy Clinical Trial Nears Completion of Enrollment
- Biomerica Reports Fiscal 2021 1st Quarter Financial Results
- Biomerica Reports Fiscal Year End May 31, 2020 Financial Results
- Biomerica Announces Retirement of Chief Financial Officer (CFO), hiring of new CFO and appointment of new member to the Board of Directors
- Biomerica Announces Notice of Allowance for New U.S. Patent Application Covering Diagnostic Guided Therapy for Irritable Bowel Syndrome (IBS) and Provides Progress Update on COVID-19 antibody tests
- Biomerica Announces Filing of New Three Year Shelf Registration Statement
- The University of Texas Health Science Center at Houston joins Biomerica’s InFoods® Irritable Bowel Syndrome ("IBS") Diagnostic-Guided Therapy (“DGT”) clinical trial
-
Biomerica, Inc. - BMRA Stock Chart Technical Analysis for 06-22-2020
- Biomerica files for FDA Emergency Use Authorization (EUA) of its Unique Laboratory Antibody Test for COVID-19
- Mayo Clinic joins Biomerica’s InFoods® Irritable Bowel Syndrome ("IBS") Diagnostic-Guided Therapy clinical trial
- Biomerica Receives CE mark for New High-Volume Version of 10 Minute Test for COVID-19 Exposure and Expands International Distribution
- Biomerica Announces Third Quarter Financial Results
- Biomerica Signs Two Definitive Agreements with Mount Sinai Medical School in New York to Scale-up a Laboratory Version Serological Test for COVID-19 That Enables High-Volume Screenings in Labs
-
Biomerica, Inc. - BMRA Stock Chart Technical Analysis for 03-18-2020
- Biomerica Begins Shipping Samples of 10 Minute Test for COVID-19 Virus Exposure
- Biomerica Announces $2.0 Million Investment by Palm Global Small Cap Master Fund
- Biomerica Announces Second Quarter Financial Results; Sales Up 6.4% for the Quarter
- Houston Methodist (part of Texas Medical Center) to start patient enrollment for Biomerica’s InFoods® Irritable Bowel Syndrome (IBS) diagnostic guided therapy clinical trial
- Biomerica Reports 1st Quarter Fiscal 2020 Financials
- Biomerica Announces Fiscal Year End 2019 Financial Results
- Republic of Colombia’s food and drug regulatory agency grants clearance for Biomerica’s colorectal cancer screening test to be sold in Colombia
- Biomerica signs exclusive distribution agreement in China for its colorectal screening test with total minimum purchase requirement of $17 million over 7 years and an upfront pre-payment of $1 million.
